Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_assertion type Assertion NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_head.
- NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_assertion description "[Using immunohistochemistry, a score including PAK1 and co-expression of PKA and ER?S305-P (PKA/ER?S305-P) was developed on a training set consisting of 103 patients treated with tamoxifen for metastatic disease, and validated on 231 patients randomized between adjuvant tamoxifen or no treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_provenance.
- NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_assertion evidence source_evidence_literature NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_provenance.
- NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_assertion SIO_000772 20213082 NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_provenance.
- NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_assertion wasDerivedFrom befree-20150227 NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_provenance.
- NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_assertion wasGeneratedBy ECO_0000203 NP608193.RARiDH4SPNJOCcl-mc4DXHRleK-TQ4KpS73Q0E3DhZzpI130_provenance.